Towards an Early Integration of Palliative Care in Oncology

Completed

• Conditions: Metastatic Cancer; Palliatives Treatments

• Registration Number: NCT05339945
• Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Brief Summary

The primary objective of the study is to describe the nature and to estimate the prevalence the health needs of patients with metastatic cancer and their main caregivers, between the period from diagnosis to death.

As secondary objectives, the study aims:

* to determinate the proportion of patients with an indication for palliative care according to Hui et al., and to describe the adequation of health needs and the services for them;

* to study the association between clinical pathway and the indication of targeted palliative care;

* to study the association between the integration of palliative care service and the adequation of health needs service of patients;

* to study the factors such as the disease, the practice and the care, contribute to the patient's survivor of 1 year.

Detailed Description

This is a descriptive, transversal, multicenter study, which will be performed in healthcare facilities in Ile de France area.

Each investigator center will be composed by oncologist / palliative care and support team. 10 centers will participate to the study, enrollement will be perfomed during 6 months targetting 400 patients with advanced cancer.

Study Timeline

• Study First Submitted: 2022-04-06
• Study First Submitted QC: 2022-04-15
• Study First Posted: 2022-04-21
• Study Start: 2022-06-02
• Primary Completion: 2024-05-10
• Study Completion: 2024-10-21
• Status Verified: 2024-11
• Last Update Submitted: 2024-12-03
• Last Update Posted: 2024-12-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 361

Inclusion Criteria

• Patients ≥ 18 years;
• Diagnosed metastatic cancer;
• Outpatient or inpatient care at a participating site to the study;
• Affiliation to the social security scheme;
• Patient informed and non-opposed to participate to the study.

Exclusion Criteria

• Testicular or choriocarcinoma ovarian cancer;
• Hematology cancer;
• No understanding french language;
• Unable to express if needed his non-opposition opinion, according to physician investigator;
• Visually impaired, hearing impaired or aphasic.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Auto-evaluation	at baseline	Evaluation by patient and principal caregiver the health needs.; Questionnaires: Echelle de Zarit.

Secondary Outcome Measures

Name	Time	Method
Clinical trajectory description	at baseline
Survivor (%)	at 1 year	Vital statute of patients at 1 year
Description of disease	at baseline
Proportion (%) of patients needing palliative treatment	at the end of study

Trial Locations

Locations (1)

Mobile palliative care and support team, Ambroise Paré hospital, APHP; 🇫🇷 Boulogne-Billancourt, France